Sagida Bibi
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Microbiology top 10%
- Bacterial Infections and Vaccines
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 2
-
- Influenza Virus Research Studies 3
- Pneumonia and Respiratory Infections 2
- Co-authors
- Eric Lattmann (2 shared papers)Afzal R. Mohammed (2 shared papers)Yvonne Perrie (2 shared papers)Jitinder Wilkhu (1 shared paper)Sarah E. McNeil (1 shared paper)Randip Kaur (1 shared paper)Dennis Christensen (1 shared paper)Malou Henriksen‐Lacey (1 shared paper)
- Journals
- Nature Communications (2 papers)Frontiers in Immunology (2 papers)PLoS Pathogens (1 paper)Science Translational Medicine (1 paper)Science Immunology (1 paper)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Sagida Bibi
14 papers receiving 334 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 107
- Microbiology 47
- Pharmaceutical Science 38
- Infectious Diseases 82
- Molecular Biology 138
Countries citing papers authored by Sagida Bibi
This map shows the geographic impact of Sagida Bibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sagida Bibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sagida Bibi more than expected).
Fields of papers citing papers by Sagida Bibi
This network shows the impact of papers produced by Sagida Bibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sagida Bibi. The network helps show where Sagida Bibi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sagida Bibi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 104 | |
| 2 | 2010 | 103 | |
| 3 | 2021 | 59 | |
| 4 | 2021 | 23 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 8 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 5 | |
| 10 | Autosomal Recessive Chronic Granulomatous Disease, IgA Deficiency and Refractory Autoimmune Thrombocytopenia Responding to Anti-CD20 Monoclonal Antibody | 2008 | 4 |
| 11 | 2020 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 0 |
About Sagida Bibi
Sagida Bibi is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Immunology and Molecular Biology, having authored 15 papers that have together received 342 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Bacterial Infections and Vaccines (4 papers), Influenza Virus Research Studies (3 papers), Lipid Membrane Structure and Behavior (2 papers), Nanoparticle-Based Drug Delivery (2 papers), COVID-19 Clinical Research Studies (2 papers), Pneumonia and Respiratory Infections (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biomaterials (107 citations), Microbiology (47 citations), Pharmaceutical Science (38 citations), Infectious Diseases (82 citations) and Molecular Biology (138 citations). Sagida Bibi has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Eric Lattmann, Afzal R. Mohammed, Yvonne Perrie, Jitinder Wilkhu, Sarah E. McNeil, Randip Kaur, Dennis Christensen, Malou Henriksen‐Lacey, Andrew J. Pollard and Kelly McGlinchey. Their work appears in journals such as Nature Communications, Frontiers in Immunology, PLoS Pathogens, Science Translational Medicine and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.